Many people are familiar with cancers such as MDS and leukemia but few understand what causes these illness or how they are treated. It is important to understand the myelodysplastic syndromes (MDS) before asking further questions on the subject.
The MDS syndrome is composed of a number of hematological conditions that result when the body lacks a certain amount of red and white blood cells. Problems with the bone marrow stem cell cause an abnormal blood cell production in the bloodstream, which often leads to MDS. Previously known as pre-leukemia, this type of cancer almost always develops into cancer of the blood or leukemia.
The Causes of MDS
Patients suffering from MDS syndrome are those who experience erratic production and reproduction of blood cells. This means that the patient's blood makes itself known by producing adverse defects in the cells responsible for blood formation. This dilemma with the blood cells can continue to worsen, leading to the gradual deterioration of the bone marrow.
Aside from genetic factors, environmental ones are also being looked into with regards to the cause of abnormalities in otherwise healthy cells in a human body (in turn producing cancer-causing ones).
Exposure to toxic chemicals such as Benzene is one of the top causes of different types of cancer. Benzene is used in the production of various items such as gasoline, cigarettes and sodas. People who eventually develop MDS and other types of cancers are most of the time oblivious to the fact that have already been exposed to Benzene by ingesting, handling or inhaling the toxic substance
Caution Signs
About one-third of MDS patients experience a deterioration in their health after their initial diagnosis. This often leads to the development of acute myelogenous leukemia or AML. Some of the most common symptoms of MDS are:
*Paleness of skin
*Bruising and/or bleeding
*Experiencing extreme fatigue
*Recurring infections
If you have been exposed to benzene and are now experiencing symptoms of MDS is is important to speak with an experienced benzene attorney to have your case evaluated.
The MDS syndrome is composed of a number of hematological conditions that result when the body lacks a certain amount of red and white blood cells. Problems with the bone marrow stem cell cause an abnormal blood cell production in the bloodstream, which often leads to MDS. Previously known as pre-leukemia, this type of cancer almost always develops into cancer of the blood or leukemia.
The Causes of MDS
Patients suffering from MDS syndrome are those who experience erratic production and reproduction of blood cells. This means that the patient's blood makes itself known by producing adverse defects in the cells responsible for blood formation. This dilemma with the blood cells can continue to worsen, leading to the gradual deterioration of the bone marrow.
Aside from genetic factors, environmental ones are also being looked into with regards to the cause of abnormalities in otherwise healthy cells in a human body (in turn producing cancer-causing ones).
Exposure to toxic chemicals such as Benzene is one of the top causes of different types of cancer. Benzene is used in the production of various items such as gasoline, cigarettes and sodas. People who eventually develop MDS and other types of cancers are most of the time oblivious to the fact that have already been exposed to Benzene by ingesting, handling or inhaling the toxic substance
Caution Signs
About one-third of MDS patients experience a deterioration in their health after their initial diagnosis. This often leads to the development of acute myelogenous leukemia or AML. Some of the most common symptoms of MDS are:
*Paleness of skin
*Bruising and/or bleeding
*Experiencing extreme fatigue
*Recurring infections
If you have been exposed to benzene and are now experiencing symptoms of MDS is is important to speak with an experienced benzene attorney to have your case evaluated.
About the Author:
Look for more information about MDS and how it can be related to exposure to benzene at the Benzene Leukemia Lawblog
No comments:
Post a Comment